Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer

Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer

Lung cancer is the leading cause of cancer-related deaths worldwide. With a focus on histology, there are two major subtypes: Non-small cell lung cancer (NSCLC) (the more frequent subtype), and small cell lung cancer (SCLC) (the more aggressive one). Even though SCLC, in general, is a chemosensitive...

Full description

Bibliographic Details
Main Authors: Arik Bernard Schulze, Georg Evers, Andrea Kerkhoff, Michael Mohr, Christoph Schliemann, Wolfgang E. Berdel, Lars Henning Schmidt
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:Cancers
Subjects:
SCLC
anti-angiogenesis
apoptosis
epigenetics
targeted therapy
Online Access:https://www.mdpi.com/2072-6694/11/5/690

Internet

https://www.mdpi.com/2072-6694/11/5/690

Similar Items